ArticleCancer chemotherapy and pharmacology2026

Research and development of a multi-target HER2 inhibitor (CPD 1) and its mechanism and application in combating HER2-positive breast cancer.

Jianchao Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.